Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Sponsor: Celltrion
Summary
Phase 3 study to assess the Efficacy and Safety of CT-L02-301 in Type 2 Diabetes Patients with Insufficient Glycemic Control with Metformin and Alogliptin Combination Therapy.
Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trial and Open-Label Extension Study to Evaluate the Efficacy and Safety of Add-On Therapy With Empagliflozin for Patients With Inadequately Controlled Type 2 DiabetesMellitus in the Combination Treatment With Metformin and Alogliptin
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
171
Start Date
2025-07-18
Completion Date
2027-04
Last Updated
2025-08-11
Healthy Volunteers
No
Conditions
Interventions
Metformin
tablets, QD, oral administration
Alogliptin
tablets, QD, oral administration
empagliflozin
tablets, QD, oral administration
Locations (1)
Celltrion
Seoul, South Korea